BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

891 related articles for article (PubMed ID: 29454382)

  • 1. High risk human papillomavirus prevalence and genotype distribution among women infected with HIV in Manaus, Amazonas.
    Teixeira MF; Sabidó M; Leturiondo AL; de Oliveira Ferreira C; Torres KL; Benzaken AS
    Virol J; 2018 Feb; 15(1):36. PubMed ID: 29454382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of cervical human papillomavirus (HPV) infection and squamous intraepithelial lesions (SIL) among a cohort of HIV-infected and uninfected Ghanaian women.
    Obiri-Yeboah D; Akakpo PK; Mutocheluh M; Adjei-Danso E; Allornuvor G; Amoako-Sakyi D; Adu-Sarkodie Y; Mayaud P
    BMC Cancer; 2017 Oct; 17(1):688. PubMed ID: 29037188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anal human papillomavirus (HPV) prevalences and factors associated with abnormal anal cytology in HIV-infected women in an urban cohort from Rio de Janeiro, Brazil.
    Cambou MC; Luz PM; Lake JE; Levi JE; Coutinho JR; de Andrade A; Heinke T; Derrico M; Veloso VG; Friedman RK; Grinsztejn B
    AIDS Patient Care STDS; 2015 Jan; 29(1):4-12. PubMed ID: 25361401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-risk papillomavirus infection among women living with human Immunodeficiency virus: Brazilian multicentric study.
    Miranda AE; Silveira MF; Travassos AG; Tenório T; Val ICC; Lannoy L; Mattos Junior HS; Carvalho NS
    J Med Virol; 2017 Dec; 89(12):2217-2223. PubMed ID: 28771777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus infection and cytologic abnormalities of the anus and cervix among HIV-infected women in the study to understand the natural history of HIV/AIDS in the era of effective therapy (the SUN study).
    Kojic EM; Cu-Uvin S; Conley L; Bush T; Onyekwuluje J; Swan DC; Unger ER; Henry K; Hammer JH; Overton ET; Darragh TM; Palefsky JM; Vellozzi C; Patel P; Brooks JT
    Sex Transm Dis; 2011 Apr; 38(4):253-9. PubMed ID: 20966828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical Human Papillomavirus genotypes in HIV-infected women: a cross-sectional analysis of the VALHIDATE study.
    Orlando G; Bianchi S; Fasolo MM; Mazza F; Frati ER; Rizzardini G; Matteelli A; Zanchetta N; Amendola A; Tanzi E
    J Prev Med Hyg; 2017 Dec; 58(4):E259-E265. PubMed ID: 29707656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus prevalence, viral load and pre-cancerous lesions of the cervix in women initiating highly active antiretroviral therapy in South Africa: a cross-sectional study.
    Moodley JR; Constant D; Hoffman M; Salimo A; Allan B; Rybicki E; Hitzeroth I; Williamson AL
    BMC Cancer; 2009 Aug; 9():275. PubMed ID: 19664216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency and multiplicity of human papillomavirus infection in HIV-1 positive women in Italy.
    Garbuglia AR; Piselli P; Lapa D; Sias C; Del Nonno F; Baiocchini A; Cimaglia C; Agresta A; Capobianchi MR
    J Clin Virol; 2012 Jun; 54(2):141-6. PubMed ID: 22437054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cross-sectional study of high-risk human papillomavirus clustering and cervical outcomes in HIV-infected women in Rio de Janeiro, Brazil.
    Castilho JL; Levi JE; Luz PM; Cambou MC; Vanni T; de Andrade A; Derrico M; Veloso VG; Grinsztejn B; Friedman RK
    BMC Cancer; 2015 Jun; 15():478. PubMed ID: 26100400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and genotype distribution of human papillomavirus in women living with HIV/AIDS in an area of Northeast Brazil.
    da Silva BEB; Santos VS; Santos IER; Araújo ED; Alves MV; Silva LADS; de Aragão Batista MV; de Lemos LMD
    J Med Virol; 2020 Dec; 92(12):3279-3287. PubMed ID: 32330294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and genotype-specific distribution of human papillomavirus in Burundi according to HIV status and urban or rural residence and its implications for control.
    Ndizeye Z; Vanden Broeck D; Lebelo RL; Bogers J; Benoy I; Van Geertruyden JP
    PLoS One; 2019; 14(6):e0209303. PubMed ID: 31237894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and immunogenicity of the quadrivalent human papillomavirus (qHPV) vaccine in HIV-positive Spanish men who have sex with men (MSM).
    Hidalgo-Tenorio C; Ramírez-Taboada J; Gil-Anguita C; Esquivias J; Omar-Mohamed-Balgahata M; SamPedro A; Lopez-Ruz M; Pasquau J
    AIDS Res Ther; 2017 Jul; 14(1):34. PubMed ID: 28720147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papilloma virus infection in HIV-infected women in Belgium: implications for prophylactic vaccines within this subpopulation.
    Menon S; Rossi R; Benoy I; Bogers JP; van den Broeck D
    Eur J Cancer Prev; 2018 Jan; 27(1):46-53. PubMed ID: 27359375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and distribution of cervical high-risk human papillomavirus and cytological abnormalities in women living with HIV in Denmark - the SHADE.
    Thorsteinsson K; Storgaard M; Katzenstein TL; Ladelund S; Rønsholt FF; Johansen IS; Pedersen G; Hashemi L; Nielsen LN; Nilas L; Obel N; Bonde J; Lebech AM
    BMC Cancer; 2016 Nov; 16(1):866. PubMed ID: 27821088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus detection in women with and without human immunodeficiency virus infection in Colombia.
    Camargo M; Soto-De Leon SC; Munoz M; Sanchez R; Peña-Herrera D; Pineda-Peña AC; Sussmann O; Paez C; Perez-Prados A; Patarroyo ME; Patarroyo MA
    BMC Cancer; 2014 Jun; 14():451. PubMed ID: 24942545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Papillomavirus infection and cervical lesions in HIV infected women on antiretroviral treatment in Thailand.
    Delory T; Ngo-Giang-Huong N; Rangdaeng S; Chotivanich N; Limtrakul A; Putiyanun C; Suriyachai P; Matanasarawut W; Jarupanich T; Liampongsabuddhi P; Heard I; Jourdain G; Lallemant M; Le Coeur S;
    J Infect; 2017 May; 74(5):501-511. PubMed ID: 28254419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence and incidence of HPV-related anal cancer precursor lesions in HIV-positive women in the late HAART era.
    Hidalgo-Tenorio C; de Jesus SE; Esquivias J; Pasquau J
    Enferm Infecc Microbiol Clin (Engl Ed); 2018 Nov; 36(9):555-562. PubMed ID: 29208455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV/HPV co-infection during pregnancy in southeastern Brazil: prevalence, HPV types, cytological abnormalities and risk factors.
    Meyrelles ARI; Siqueira JD; Hofer CB; Costa TP; Azevedo AP; Guimarães BV; Seuánez HN; Soares MA; Almeida G; Soares EA; Machado ES
    Gynecol Oncol; 2013 Jan; 128(1):107-112. PubMed ID: 23063764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of and Risk Factors for Anal Oncogenic Human Papillomavirus Infection Among HIV-Infected Women in France in the Combination Antiretroviral Therapy Era.
    Heard I; Poizot-Martin I; Potard V; Etienney I; Crenn-Hebert C; Moore C; Touraine P; Cubie H; Costagliola D;
    J Infect Dis; 2016 May; 213(9):1455-61. PubMed ID: 26690345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2.
    Hawes SE; Critchlow CW; Sow PS; Touré P; N'Doye I; Diop A; Kuypers JM; Kasse AA; Kiviat NB
    J Natl Cancer Inst; 2006 Jan; 98(2):100-9. PubMed ID: 16418512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.